220 related articles for article (PubMed ID: 10639453)
1. Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.
Goldman DL; Lee SC; Mednick AJ; Montella L; Casadevall A
Infect Immun; 2000 Feb; 68(2):832-8. PubMed ID: 10639453
[TBL] [Abstract][Full Text] [Related]
2. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide.
Rivera J; Mukherjee J; Weiss LM; Casadevall A
J Immunol; 2002 Apr; 168(7):3419-27. PubMed ID: 11907100
[TBL] [Abstract][Full Text] [Related]
3. Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas.
Goldman D; Cho Y; Zhao M; Casadevall A; Lee SC
Am J Pathol; 1996 Apr; 148(4):1275-82. PubMed ID: 8644868
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.
Kakeya H; Udono H; Maesaki S; Sasaki E; Kawamura S; Hossain MA; Yamamoto Y; Sawai T; Fukuda M; Mitsutake K; Miyazaki Y; Tomono K; Tashiro T; Nakayama E; Kohno S
Clin Exp Immunol; 1999 Mar; 115(3):485-90. PubMed ID: 10193422
[TBL] [Abstract][Full Text] [Related]
5. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.
Goldman D; Lee SC; Casadevall A
Infect Immun; 1994 Nov; 62(11):4755-61. PubMed ID: 7927751
[TBL] [Abstract][Full Text] [Related]
7. A dual role for TGF-beta1 in the control and persistence of fungal pneumonia.
Shao X; Rivera J; Niang R; Casadevall A; Goldman DL
J Immunol; 2005 Nov; 175(10):6757-63. PubMed ID: 16272332
[TBL] [Abstract][Full Text] [Related]
8. Phagocytic activity and monocyte chemotactic protein expression by pulmonary macrophages in persistent pulmonary cryptococcosis.
He W; Casadevall A; Lee SC; Goldman DL
Infect Immun; 2003 Feb; 71(2):930-6. PubMed ID: 12540575
[TBL] [Abstract][Full Text] [Related]
9. Role of IFN-gamma in regulating T2 immunity and the development of alternatively activated macrophages during allergic bronchopulmonary mycosis.
Arora S; Hernandez Y; Erb-Downward JR; McDonald RA; Toews GB; Huffnagle GB
J Immunol; 2005 May; 174(10):6346-56. PubMed ID: 15879135
[TBL] [Abstract][Full Text] [Related]
10. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain.
Wormley FL; Cox GM; Perfect JR
Microb Pathog; 2005; 38(2-3):113-23. PubMed ID: 15748813
[TBL] [Abstract][Full Text] [Related]
12. Cryptococcus neoformans meningitis in the rat.
Goldman DL; Casadevall A; Cho Y; Lee SC
Lab Invest; 1996 Dec; 75(6):759-70. PubMed ID: 8973471
[TBL] [Abstract][Full Text] [Related]
13. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary cryptococcosis in the rat.
Graybill JR; Ahrens J; Nealon T; Paque R
Am Rev Respir Dis; 1983 May; 127(5):636-40. PubMed ID: 6342482
[TBL] [Abstract][Full Text] [Related]
15. DAP12 Inhibits Pulmonary Immune Responses to Cryptococcus neoformans.
Heung LJ; Hohl TM
Infect Immun; 2016 Jun; 84(6):1879-86. PubMed ID: 27068093
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to Cryptococcus neoformans proteins in rodents and humans.
Chen LC; Goldman DL; Doering TL; Pirofski La; Casadevall A
Infect Immun; 1999 May; 67(5):2218-24. PubMed ID: 10225877
[TBL] [Abstract][Full Text] [Related]
17. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.
Arora S; Olszewski MA; Tsang TM; McDonald RA; Toews GB; Huffnagle GB
Infect Immun; 2011 May; 79(5):1915-26. PubMed ID: 21383052
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcus neoformans infection can elicit protective antibodies in mice.
Mukherjee J; Scharff MD; Casadevall A
Can J Microbiol; 1994 Oct; 40(10):888-92. PubMed ID: 8000967
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans Evades Pulmonary Immunity by Modulating Xylose Precursor Transport.
Li LX; Hole CR; Rangel-Moreno J; Khader SA; Doering TL
Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32423915
[No Abstract] [Full Text] [Related]
20. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
Hardison SE; Wozniak KL; Kolls JK; Wormley FL
Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]